Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Lustig Marc — BriaCell Therapeutics Corp. insider: 2 transactions · InsiderLens

Home / Insiders / Lustig Marc

Lustig Marc

10% owner at BriaCell Therapeutics Corp. · on record since May 20, 2024
Director at BriaCell Therapeutics Corp. · on record since Aug 2, 2022

Insider trading activity of Lustig Marc

Transactions on record: 2; since May 20, 2024

Open-market buys: 1; $2M

Open-market sells: 0

Companies traded: 1; last filing May 20, 2024

Figures computed from official regulatory filings — methodology.

Companies where Lustig Marc has traded

BriaCell Therapeutics Corp.2 tx · $2M · May 20, 2024

Track record of Lustig Marc

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lustig Marc

Co-insiders of Lustig Marc

Bondarenko JamiesonBriaCell Therapeutics Corp.
Del Priore GiuseppeBriaCell Therapeutics Corp.
Embro-Pantalony Vaughn C.BriaCell Therapeutics Corp.
Gross Jane ABriaCell Therapeutics Corp.
LEVIN GADIBriaCell Therapeutics Corp.
Lopez-Lago Miguel A.BriaCell Therapeutics Corp.
Schmieg Martin E.BriaCell Therapeutics Corp.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Taub RebeccaBriaCell Therapeutics Corp.

Williams Williams V.BriaCell Therapeutics Corp.

Company	Filed	Type	Qty	Price	Value · USD	Src
BriaCell Therapeutics Corp.	May 20, 2024	BuyD	902,935	—	—	SEC
BriaCell Therapeutics Corp.	May 20, 2024	Buy	902,935	2.22 USD	$2M	SEC